US FDA’s Speed Of Work Under Trump Quietly Raising Industry Concerns

Multiple sources, including former Acting FDA Commissioner Janet Woodcock, told the Pink Sheet that industry is quietly complaining about FDA work delays and they expect the problem will worsen.

yellow sign reads slow lane ahead with arrow pointing to right.
Industry stakeholders are starting to quietly complain that the FDA's pace of work is slowing. (Shutterstock)

More from US FDA

More from Product Reviews